Emergent BioSolutions Inc. — Director's Dealing 2025

Mar 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2025-03-12

Reporting Person: Fowler Neal Franklin (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-12	Common Stock	S	35000	$5.83	Disposed	101100	Direct

Footnotes

F1: On March 12, 2025, Mr. Fowler sold an aggregate of 35,000 shares of Emergent BioSolutions Inc. common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $5.81 to $5.89. The Company maintains a record of the transactions and copies will be provided upon request.